-
1
-
-
0036305113
-
Coagulation and inflammation in acute lung injury
-
Welty-Wolf KE, Carraway MS, Ortel TL, Piantadosi CA. Coagulation and inflammation in acute lung injury. Thromb Haemost 2002, 88(1):17-25.
-
(2002)
Thromb Haemost
, vol.88
, Issue.1
, pp. 17-25
-
-
Welty-Wolf, K.E.1
Carraway, M.S.2
Ortel, T.L.3
Piantadosi, C.A.4
-
2
-
-
42249111711
-
Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases
-
Wygrecka M, Jablonska E, Guenther A, Preissner KT, Markart P. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 2008, 99(3):494-501.
-
(2008)
Thromb Haemost
, vol.99
, Issue.3
, pp. 494-501
-
-
Wygrecka, M.1
Jablonska, E.2
Guenther, A.3
Preissner, K.T.4
Markart, P.5
-
3
-
-
40349098060
-
Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?
-
2268072, 18223674
-
Chambers RC. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?. Br J Pharmacol 2008, 153(Suppl 1):S367-S378. 2268072, 18223674.
-
(2008)
Br J Pharmacol
, vol.153
, Issue.SUPPL. 1
-
-
Chambers, R.C.1
-
4
-
-
0037394513
-
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury
-
Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003, 31(4 Suppl):S213-S220.
-
(2003)
Crit Care Med
, vol.31
, Issue.4 SUPPL
-
-
Idell, S.1
-
5
-
-
0029147768
-
Tissue factor: molecular recognition and cofactor function
-
Martin DM, Boys CW, Ruf W. Tissue factor: molecular recognition and cofactor function. FASEB J 1995, 9(10):852-859.
-
(1995)
FASEB J
, vol.9
, Issue.10
, pp. 852-859
-
-
Martin, D.M.1
Boys, C.W.2
Ruf, W.3
-
6
-
-
0030070996
-
Cell biology of tissue factor, the principal initiator of blood coagulation
-
10.1016/0049-3848(95)00209-X, 8747518
-
Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996, 81(1):1-41. 10.1016/0049-3848(95)00209-X, 8747518.
-
(1996)
Thromb Res
, vol.81
, Issue.1
, pp. 1-41
-
-
Camerer, E.1
Kolsto, A.B.2
Prydz, H.3
-
7
-
-
28344436780
-
Protease-activated receptors in hemostasis, thrombosis and vascular biology
-
10.1111/j.1538-7836.2005.01377.x, 16102047
-
Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005, 3(8):1800-1814. 10.1111/j.1538-7836.2005.01377.x, 16102047.
-
(2005)
J Thromb Haemost
, vol.3
, Issue.8
, pp. 1800-1814
-
-
Coughlin, S.R.1
-
8
-
-
0034933683
-
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor
-
10.1073/pnas.141126698, 35412, 11438726
-
Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci USA 2001, 98(14):7742-7747. 10.1073/pnas.141126698, 35412, 11438726.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.14
, pp. 7742-7747
-
-
Riewald, M.1
Ruf, W.2
-
9
-
-
34447294235
-
The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor
-
10.1136/thx.2006.063305, 2117249,2117249, 17356058
-
Bastarache JA, Wang L, Geiser T, Wang Z, Albertine KH, Matthay MA, Ware LB. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax 2007, 62(7):608-616. 10.1136/thx.2006.063305, 2117249,2117249, 17356058.
-
(2007)
Thorax
, vol.62
, Issue.7
, pp. 608-616
-
-
Bastarache, J.A.1
Wang, L.2
Geiser, T.3
Wang, Z.4
Albertine, K.H.5
Matthay, M.A.6
Ware, L.B.7
-
10
-
-
71949114684
-
Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome
-
10.1152/ajplung.00214.2009, 2793184, 19700643
-
Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2009, 297(6):L1035-L1041. 10.1152/ajplung.00214.2009, 2793184, 19700643.
-
(2009)
Am J Physiol Lung Cell Mol Physiol
, vol.297
, Issue.6
-
-
Bastarache, J.A.1
Fremont, R.D.2
Kropski, J.A.3
Bossert, F.R.4
Ware, L.B.5
-
11
-
-
0026048531
-
Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome
-
Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, Maunder RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol 1991, 261(4 Pt 1):L240-L248.
-
(1991)
Am J Physiol
, vol.261
, Issue.4 PART 1
-
-
Idell, S.1
Koenig, K.B.2
Fair, D.S.3
Martin, T.R.4
McLarty, J.5
Maunder, R.J.6
-
12
-
-
74249099908
-
Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor × binding site
-
2927860, 20062929
-
Jiao JA, Kelly AB, Marzec UM, Nieves E, Acevedo J, Burkhardt M, Edwards A, Zhu XY, Chavaillaz PA, Wong A, Wong JL, Egan JO, Taylor D, Rhode PR, Wong HC. Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor × binding site. Thromb Haemost 2010, 103(1):224-233. 2927860, 20062929.
-
(2010)
Thromb Haemost
, vol.103
, Issue.1
, pp. 224-233
-
-
Jiao, J.A.1
Kelly, A.B.2
Marzec, U.M.3
Nieves, E.4
Acevedo, J.5
Burkhardt, M.6
Edwards, A.7
Zhu, X.Y.8
Chavaillaz, P.A.9
Wong, A.10
Wong, J.L.11
Egan, J.O.12
Taylor, D.13
Rhode, P.R.14
Wong, H.C.15
-
13
-
-
33644789491
-
Blockade of tissue factor-factor × binding attenuates sepsis-induced respiratory and renal failure
-
Welty-Wolf KE, Carraway MS, Ortel TL, Ghio AJ, Idell S, Egan J, Zhu X, Jiao JA, Wong HC, Piantadosi CA. Blockade of tissue factor-factor × binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol 2006, 290(1):L21-L31.
-
(2006)
Am J Physiol Lung Cell Mol Physiol
, vol.290
, Issue.1
-
-
Welty-Wolf, K.E.1
Carraway, M.S.2
Ortel, T.L.3
Ghio, A.J.4
Idell, S.5
Egan, J.6
Zhu, X.7
Jiao, J.A.8
Wong, H.C.9
Piantadosi, C.A.10
-
14
-
-
17144371857
-
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial
-
10.1093/eurheartj/ehi094, 15684280
-
Morrow DA, Murphy SA, McCabe CH, Mackman N, Wong HC, Antman EM. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial. Eur Heart J 2005, 26(7):682-688. 10.1093/eurheartj/ehi094, 15684280.
-
(2005)
Eur Heart J
, vol.26
, Issue.7
, pp. 682-688
-
-
Morrow, D.A.1
Murphy, S.A.2
McCabe, C.H.3
Mackman, N.4
Wong, H.C.5
Antman, E.M.6
-
15
-
-
66449108092
-
A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome
-
10.1097/CCM.0b013e31819fff2c, 19384216
-
Vincent JL, Artigas A, Petersen LC, Meyer C. A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome. Crit Care Med 2009, 37(6):1874-1880. 10.1097/CCM.0b013e31819fff2c, 19384216.
-
(2009)
Crit Care Med
, vol.37
, Issue.6
, pp. 1874-1880
-
-
Vincent, J.L.1
Artigas, A.2
Petersen, L.C.3
Meyer, C.4
-
16
-
-
51849153326
-
Randomized clinical trial of activated protein C for the treatment of acute lung injury
-
10.1164/rccm.200803-419OC, 2542435, 18565951
-
Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008, 178(6):618-623. 10.1164/rccm.200803-419OC, 2542435, 18565951.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, Issue.6
, pp. 618-623
-
-
Liu, K.D.1
Levitt, J.2
Zhuo, H.3
Kallet, R.H.4
Brady, S.5
Steingrub, J.6
Tidswell, M.7
Siegel, M.D.8
Soto, G.9
Peterson, M.W.10
Chesnutt, M.S.11
Phillips, C.12
Weinacker, A.13
Thompson, B.T.14
Eisner, M.D.15
Matthay, M.A.16
-
17
-
-
43349096795
-
Inflammation, endothelium, and coagulation in sepsis
-
Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83(3):536-545.
-
(2008)
J Leukoc Biol
, vol.83
, Issue.3
, pp. 536-545
-
-
Schouten, M.1
Wiersinga, W.J.2
Levi, M.3
van der Poll, T.4
-
18
-
-
67849130574
-
The many faces of tissue factor
-
2834482, 19630786
-
Mackman N. The many faces of tissue factor. J Thromb Haemost 2009, 7(Suppl 1):136-139. 2834482, 19630786.
-
(2009)
J Thromb Haemost
, vol.7
, Issue.SUPPL. 1
, pp. 136-139
-
-
Mackman, N.1
-
19
-
-
8644234910
-
Antibody pharmacokinetics and pharmacodynamics
-
10.1002/jps.20178, 15389672
-
Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 2004, 93(11):2645-2668. 10.1002/jps.20178, 15389672.
-
(2004)
J Pharm Sci
, vol.93
, Issue.11
, pp. 2645-2668
-
-
Lobo, E.D.1
Hansen, R.J.2
Balthasar, J.P.3
-
20
-
-
0035826096
-
Efficacy and safety of recombinant human activated protein C for severe sepsis
-
10.1056/NEJM200103083441001, 11236773
-
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344(10):699-709. 10.1056/NEJM200103083441001, 11236773.
-
(2001)
N Engl J Med
, vol.344
, Issue.10
, pp. 699-709
-
-
Bernard, G.R.1
Vincent, J.L.2
Laterre, P.F.3
LaRosa, S.P.4
Dhainaut, J.F.5
Lopez-Rodriguez, A.6
Steingrub, J.S.7
Garber, G.E.8
Helterbrand, J.D.9
Ely, E.W.10
Fisher, C.J.11
-
21
-
-
0035904368
-
Caring for the critically ill patient
-
Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286(15):1869-1878.
-
(2001)
High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA
, vol.286
, Issue.15
, pp. 1869-1878
-
-
Warren, B.L.1
Eid, A.2
Singer, P.3
Pillay, S.S.4
Carl, P.5
Novak, I.6
Chalupa, P.7
Atherstone, A.8
Penzes, I.9
Kubler, A.10
Knaub, S.11
Keinecke, H.O.12
Heinrichs, H.13
Schindel, F.14
Juers, M.15
Bone, R.C.16
Opal, S.M.17
-
22
-
-
0038690407
-
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial
-
10.1001/jama.290.2.238, 12851279
-
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003, 290(2):238-247. 10.1001/jama.290.2.238, 12851279.
-
(2003)
JAMA
, vol.290
, Issue.2
, pp. 238-247
-
-
Abraham, E.1
Reinhart, K.2
Opal, S.3
Demeyer, I.4
Doig, C.5
Rodriguez, A.L.6
Beale, R.7
Svoboda, P.8
Laterre, P.F.9
Simon, S.10
Light, B.11
Spapen, H.12
Stone, J.13
Seibert, A.14
Peckelsen, C.15
De Deyne, C.16
Postier, R.17
Pettila, V.18
Artigas, A.19
Percell, S.R.20
Shu, V.21
Zwingelstein, C.22
Tobias, J.23
Poole, L.24
Stolzenbach, J.C.25
Creasey, A.A.26
more..
-
23
-
-
25444492831
-
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
-
10.1056/NEJMoa050935, 16192478
-
Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005, 353(13):1332-1341. 10.1056/NEJMoa050935, 16192478.
-
(2005)
N Engl J Med
, vol.353
, Issue.13
, pp. 1332-1341
-
-
Abraham, E.1
Laterre, P.F.2
Garg, R.3
Levy, H.4
Talwar, D.5
Trzaskoma, B.L.6
Francois, B.7
Guy, J.S.8
Bruckmann, M.9
Rea-Neto, A.10
Rossaint, R.11
Perrotin, D.12
Sablotzki, A.13
Arkins, N.14
Utterback, B.G.15
Macias, W.L.16
-
24
-
-
33847687731
-
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial
-
10.1016/S0140-6736(07)60411-5, 17350452
-
Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, Abd-Allah SA, Levy H, Angle R, Wang D, Sundin DP, Giroir B. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007, 369(9564):836-843. 10.1016/S0140-6736(07)60411-5, 17350452.
-
(2007)
Lancet
, vol.369
, Issue.9564
, pp. 836-843
-
-
Nadel, S.1
Goldstein, B.2
Williams, M.D.3
Dalton, H.4
Peters, M.5
Macias, W.L.6
Abd-Allah, S.A.7
Levy, H.8
Angle, R.9
Wang, D.10
Sundin, D.P.11
Giroir, B.12
-
25
-
-
0033880884
-
Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line
-
10.1046/j.1365-2141.2000.02128.x, 10930989
-
White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, O'Neill L, Kelleher D, Schwarz HP, Smith OP. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol 2000, 110(1):130-134. 10.1046/j.1365-2141.2000.02128.x, 10930989.
-
(2000)
Br J Haematol
, vol.110
, Issue.1
, pp. 130-134
-
-
White, B.1
Schmidt, M.2
Murphy, C.3
Livingstone, W.4
O'Toole, D.5
Lawler, M.6
O'Neill, L.7
Kelleher, D.8
Schwarz, H.P.9
Smith, O.P.10
-
26
-
-
0029626658
-
Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses
-
10.1097/00007890-199560120-00026, 8545885
-
Hancock WW, Grey ST, Hau L, Akalin E, Orthner C, Sayegh MH, Salem HH. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 1995, 60(12):1525-1532. 10.1097/00007890-199560120-00026, 8545885.
-
(1995)
Transplantation
, vol.60
, Issue.12
, pp. 1525-1532
-
-
Hancock, W.W.1
Grey, S.T.2
Hau, L.3
Akalin, E.4
Orthner, C.5
Sayegh, M.H.6
Salem, H.H.7
-
27
-
-
0042530424
-
Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C
-
10.1067/mai.2003.1609, 12897745
-
Feistritzer C, Sturn DH, Kaneider NC, Djanani A, Wiedermann CJ. Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C. J Allergy Clin Immunol 2003, 112(2):375-381. 10.1067/mai.2003.1609, 12897745.
-
(2003)
J Allergy Clin Immunol
, vol.112
, Issue.2
, pp. 375-381
-
-
Feistritzer, C.1
Sturn, D.H.2
Kaneider, N.C.3
Djanani, A.4
Wiedermann, C.J.5
-
28
-
-
0037036069
-
Activation of endothelial cell protease activated receptor 1 by the protein C pathway
-
10.1126/science.1071699, 12052963
-
Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002, 296(5574):1880-1882. 10.1126/science.1071699, 12052963.
-
(2002)
Science
, vol.296
, Issue.5574
, pp. 1880-1882
-
-
Riewald, M.1
Petrovan, R.J.2
Donner, A.3
Mueller, B.M.4
Ruf, W.5
-
29
-
-
0037352279
-
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
-
10.1038/nm826, 12563316
-
Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 2003, 9(3):338-342. 10.1038/nm826, 12563316.
-
(2003)
Nat Med
, vol.9
, Issue.3
, pp. 338-342
-
-
Cheng, T.1
Liu, D.2
Griffin, J.H.3
Fernandez, J.A.4
Castellino, F.5
Rosen, E.D.6
Fukudome, K.7
Zlokovic, B.V.8
-
30
-
-
34147119744
-
The cytoprotective protein C pathway
-
10.1182/blood-2006-09-003004, 17110453
-
Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007, 109(8):3161-3172. 10.1182/blood-2006-09-003004, 17110453.
-
(2007)
Blood
, vol.109
, Issue.8
, pp. 3161-3172
-
-
Mosnier, L.O.1
Zlokovic, B.V.2
Griffin, J.H.3
-
31
-
-
33646559569
-
Roles of protease-activated receptors in a mouse model of endotoxemia
-
10.1182/blood-2005-08-3130, 1895289, 16434493
-
Camerer E, Cornelissen I, Kataoka H, Duong DN, Zheng YW, Coughlin SR. Roles of protease-activated receptors in a mouse model of endotoxemia. Blood 2006, 107(10):3912-3921. 10.1182/blood-2005-08-3130, 1895289, 16434493.
-
(2006)
Blood
, vol.107
, Issue.10
, pp. 3912-3921
-
-
Camerer, E.1
Cornelissen, I.2
Kataoka, H.3
Duong, D.N.4
Zheng, Y.W.5
Coughlin, S.R.6
-
32
-
-
40349085619
-
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
-
2268078, 18059329
-
Ramachandran R, Hollenberg MD. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 2008, 153(S1):S263-S282. 2268078, 18059329.
-
(2008)
Br J Pharmacol
, vol.153
, Issue.S1
-
-
Ramachandran, R.1
Hollenberg, M.D.2
-
33
-
-
23444455036
-
Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms
-
Su X, Camerer E, Hamilton JR, Coughlin SR, Matthay MA. Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 2005, 175(4):2598-2605.
-
(2005)
J Immunol
, vol.175
, Issue.4
, pp. 2598-2605
-
-
Su, X.1
Camerer, E.2
Hamilton, J.R.3
Coughlin, S.R.4
Matthay, M.A.5
-
34
-
-
70349422341
-
Increased local expression of coagulation factor × contributes to the fibrotic response in human and murine lung injury
-
2735922, 19652365
-
Scotton CJ, Krupiczojc MA, Konigshoff M, Mercer PF, Lee YC, Kaminski N, Morser J, Post JM, Maher TM, Nicholson AG, Moffatt JD, Laurent GJ, Derian CK, Eickelberg O, Chambers RC. Increased local expression of coagulation factor × contributes to the fibrotic response in human and murine lung injury. J Clin Invest 2009, 119(9):2550-2563. 2735922, 19652365.
-
(2009)
J Clin Invest
, vol.119
, Issue.9
, pp. 2550-2563
-
-
Scotton, C.J.1
Krupiczojc, M.A.2
Konigshoff, M.3
Mercer, P.F.4
Lee, Y.C.5
Kaminski, N.6
Morser, J.7
Post, J.M.8
Maher, T.M.9
Nicholson, A.G.10
Moffatt, J.D.11
Laurent, G.J.12
Derian, C.K.13
Eickelberg, O.14
Chambers, R.C.15
-
35
-
-
17844399243
-
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis
-
10.1016/S0002-9440(10)62354-1, 1606391, 15855637
-
Howell DC, Johns RH, Lasky JA, Shan B, Scotton CJ, Laurent GJ, Chambers RC. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol 2005, 166(5):1353-1365. 10.1016/S0002-9440(10)62354-1, 1606391, 15855637.
-
(2005)
Am J Pathol
, vol.166
, Issue.5
, pp. 1353-1365
-
-
Howell, D.C.1
Johns, R.H.2
Lasky, J.A.3
Shan, B.4
Scotton, C.J.5
Laurent, G.J.6
Chambers, R.C.7
|